Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypoxia-inducible factor-1 and oncogenic signalling.

Julia I Bárdos1, Margaret Ashcroft

  • 1Cell Growth Regulation and Angiogenesis Laboratory, Centre for Cancer Therapeutics, Institute of Cancer Research, Sutton, UK.

Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|February 28, 2004
PubMed
Summary

Hypoxia-inducible factor 1 (HIF-1) activation in cancer, driven by microenvironmental stress and genetic changes, promotes tumor growth and metastasis. Understanding HIF-1 regulation is key to developing new cancer therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biallelic variants in CHCHD4 are associated with combined OXPHOS defect leading to mitochondrial disease.

HGG advances·2026
Same author

The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells.

eLife·2025
Same author

CHCHD4 regulates the expression of mitochondrial genes that are essential for tumour cell growth.

Biochimica et biophysica acta. Molecular basis of disease·2024
Same author

The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells.

Research square·2024
Same author

Integrative transcriptomic and metabolic analyses of the mammalian hibernating brain identifies a key role for succinate dehydrogenase in ischemic tolerance.

bioRxiv : the preprint server for biology·2023
Same author

Enhanced hepatic respiratory capacity and altered lipid metabolism support metabolic homeostasis during short-term hypoxic stress.

BMC biology·2021

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Hypoxia-inducible factor 1 (HIF-1) plays a critical role in cellular adaptation to low oxygen conditions.
  • HIF-1 activation is frequently observed in human cancers, contributing to tumor progression and aggressiveness.
  • Deregulation of HIF-1 is linked to poor outcomes in conventional cancer therapies.

Purpose of the Study:

  • To elucidate the mechanisms underlying HIF-1 activation in response to hypoxic stress and oncogenic signals.
  • To explore the implications of HIF-1 deregulation in human cancer.
  • To identify potential therapeutic targets for novel cancer treatments based on HIF-1 regulation.

Main Methods:

  • Review and synthesis of existing literature on HIF-1 activation pathways.

Related Experiment Videos

  • Analysis of genetic and microenvironmental factors influencing HIF-1 activity.
  • Investigation of signaling cascades converging on HIF-1alpha.

    • Main Results:

    • HIF-1 activation is promoted by microenvironmental factors (hypoxia, growth factors) and genetic alterations (e.g., p53, PTEN, pVHL inactivation).
    • Activated HIF-1 confers survival and proliferation advantages to cancer cells, fostering vascular tumor formation, aggression, and metastasis.
    • Upregulation of HIF-1alpha, a key HIF-1 component, correlates with poor treatment outcomes.

    Conclusions:

    • Understanding HIF-1 activation mechanisms is crucial for comprehending cancer deregulation.
    • HIF-1 signaling networks offer promising avenues for developing innovative cancer therapies.
    • Targeting HIF-1 regulation could lead to improved treatment strategies for aggressive and metastatic tumors.